Hello dear friends!
Today I will tell you about the shares of the company that I bought in March 2021, because I think they are quite promising both in the medium and long term.
It will be about the shares of a pharmaceutical company Merck & Company Inc (MRK)…
Why did the choice fall on Merck?
I’ll start with the fundamental factors:
one. The US federal government plans to spend $ 100 million to help a recently announced vaccine partnership between Merck & Co and rival Johnson & Johnson.
2. The experimental antiviral drug molnupiravir, which Merck is developing with Ridgeback Bio, showed a faster reduction of the infectious virus in its phase 2a study among participants with early COVID-19.
“The secondary objective results from this study of a faster reduction of infectious virus among people with early-stage COVID-19 who received molnupiravir are promising,” said William Fisher, assistant professor of medicine at the University of North Carolina School of Medicine.
3. The company regularly pays dividends. In order to receive dividends for the last quarter, you need to purchase shares by March 12, 2021. If, before the cutoff, the shares are on the investor’s account, then he will receive dividends in the amount of $ 0.65 per share.
Technical analysis also indicates a possible rise in quotations.
The daily chart clearly shows that buyers were able to keep the price above the support at 73.00 on Friday. I also took part in this process and have already opened a long of 0.1 lots (the equivalent of 10 shares).
If the decline continues, then I plan to average this position in case of a successful test of the support level 66.80.
The nearest target for taking profit is located at the resistance 84.65.
I want to warn you right away that I try to trade stocks of companies without using leverage, because in this case, to the account opened in InstaForex, no negative swap is charged and any long squeeze can be sustained.
All profitable trades and profitable investment ideas!